Arcadia Biosciences (RKDA) Competitors

Oriental Rise Holdings Limited Ordinary Shares (NASDAQ:ORIS) and Arcadia Biosciences (NASDAQ:RKDA) are both small-cap consumer staples companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, earnings, risk, community ranking, media sentiment and valuation.

Does the media prefer ORIS or RKDA?

In the previous week, Oriental Rise Holdings Limited Ordinary Shares and Oriental Rise Holdings Limited Ordinary Shares both had 1 articles in the media. Oriental Rise Holdings Limited Ordinary Shares' average media sentiment score of 0.25 beat Arcadia Biosciences' score of 0.00 indicating that Oriental Rise Holdings Limited Ordinary Shares is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Oriental Rise Holdings Limited Ordinary Shares	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Arcadia Biosciences	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has preferable valuation and earnings, ORIS or RKDA?

Oriental Rise Holdings Limited Ordinary Shares has higher revenue and earnings than Arcadia Biosciences.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Oriental Rise Holdings Limited Ordinary Shares	$15.01M	1.23	$11.50M	N/A	N/A
Arcadia Biosciences	$5.26M	1.09	-$13.98M	-$4.28	-0.98

Is ORIS or RKDA more profitable?

Oriental Rise Holdings Limited Ordinary Shares has a net margin of 0.00% compared to Arcadia Biosciences' net margin of -110.61%. Oriental Rise Holdings Limited Ordinary Shares' return on equity of 0.00% beat Arcadia Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Oriental Rise Holdings Limited Ordinary Shares	N/A	N/A	N/A
Arcadia Biosciences	-110.61%	-52.63%	-34.57%

Do insiders and institutionals hold more shares of ORIS or RKDA?

17.7% of Arcadia Biosciences shares are owned by institutional investors. 1.8% of Arcadia Biosciences shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Do analysts rate ORIS or RKDA?

Arcadia Biosciences has a consensus target price of $6.00, indicating a potential upside of 43.03%. Given Arcadia Biosciences' stronger consensus rating and higher possible upside, analysts clearly believe Arcadia Biosciences is more favorable than Oriental Rise Holdings Limited Ordinary Shares.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Oriental Rise Holdings Limited Ordinary Shares	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Arcadia Biosciences	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Does the MarketBeat Community favor ORIS or RKDA?

Arcadia Biosciences received 286 more outperform votes than Oriental Rise Holdings Limited Ordinary Shares when rated by MarketBeat users.

Company	Underperform	Outperform
Oriental Rise Holdings Limited Ordinary Shares	N/A	N/A
Arcadia Biosciences	Outperform Votes 286 53.06%	Underperform Votes 253 46.94%

Summary

Oriental Rise Holdings Limited Ordinary Shares beats Arcadia Biosciences on 7 of the 13 factors compared between the two stocks.